Call to tighten psych screening for mefloquine

Australia should follow the lead of Europe and introduce mandatory neuropsychiatric risk screening as a condition of prescribing the antimalarial mefloquine, according to a travel medicine expert.

Doctors in EU countries are now required to fill out a contraindication checklist before writing a mefloquine script for malaria prophylaxis, to rule out patients with a history of mental illness and other risk factors that could trigger adverse effects when taking the drug.

Dr Deborah Mills, medical director of Dr Deb’s Travel Medicine Clinics in